Max Robotics — Global Service Robot Directory + US Certification

About

Thomas Krieger is a leading figure in radiation oncology, with a primary focus on stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer (NSCLC). His most impactful contribution is the landmark 2017 "Planning benchmark study for SBRT of early stage NSCLC," which has garnered 54 citations and established critical standards for treatment planning in this high-precision technique. This work systematically evaluated inter-institutional variability in SBRT planning, providing a foundational benchmark that has improved consistency and quality in clinical practice. Krieger's research addresses the technical challenges of delivering ablative radiation doses while minimizing toxicity to surrounding healthy tissue, directly influencing how radiation oncologists approach lung cancer treatment. His contributions have helped refine dose constraints, target delineation, and plan evaluation metrics, making SBRT a more reliable and effective option for patients. Through this benchmark study and related work, Krieger has shaped modern radiotherapy protocols, earning recognition as a key contributor to the advancement of evidence-based, high-precision cancer care.